Myriad Genetics | MYGN - Betriebsergebnis

Aktienkurs
4.68
Täglich Wechseln
0 0%
Monatlich
4.00%
Jährlich
-34.36%
Q2 Prognose
4.68




Betriebsergebnis Veränderung Datum
Agilent USD 353M 90M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Danaher USD 1.34B 158M 2026-03
Illumina USD 256M 6M 2025-12
J&J USD 6.62B 1.03B 2026-03
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Quidel USD -37.3M 667.5M 2025-12
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Standard Biotools USD -21.92M 1.55M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veracyte USD 24.63M 1.52M 2025-12
Waters USD 270.52M 78.4M 2025-12